Phaco thermal control system

• US 7,909,792 B2
• Filed: 10/20/2003
• Issued: 03/22/2011
• Est. Priority Date: 03/10/1998
• Status: Active Grant

• Current Assignee: Johnson & Johnson Surgical Vision, Inc. (Johnson & Johnson)
• Original Assignee: Abbott Medical Optics Incorporated (Johnson & Johnson)
• Inventors: Kadziauskas, Kenneth E., Rockley, Paul W.
• Primary Examiner(s): Mendez; Manuel A
• Application Number:
  US10/690,203
• Publication Number:
  US 20040082902A1
• Time in Patent Office: 2,710 Days
• Field of Search: 604 19- 22, 604/27, 604/28, 604/31, 604/35, 604/39, 604/40, 604/43, 604/44, 604 65- 67, 604/118, 601/2, 601/52, 607/97, 606/107, 606/159, 606167-171
• US Class Current: 604/22
• CPC Class Codes: A61B 2017/00084 Temperature
• CPC Class Codes: A61B 2017/00119 alarm; indicating an abnormal situation
• CPC Class Codes: A61B 2017/00199 with a console, e.g. a control panel with a display
• CPC Class Codes: A61F 9/00745 using mechanical vibrations, e.g. ultrasonic

Abstract

Control apparatus for an ultrasonic phacoemulsification handpiece utilizes flow rates and temperature measurements as well as power provided to a handpiece for calculating a matrix of power level duty cycle combination that would not generate sufficient heat to create a burn in eye tissue and either prevent operation of handpiece in the matrix or alert a surgeon of such use.

Claims

1. A phacoemulsification system for regulating fluid flow and energy into an eye during ocular surgery, comprising:

a handpiece;

a control console configured to provide phaco power to the handpiece, irrigation fluid to an eye; and

an aspiration source for removing fluid from the eye; and

a matrix comprising phaco power levels and fluid flow conditions that will not generate sufficient heat to create damage to eye tissue within the eye,

wherein the system is configured to control at least one of the phaco power or fluid flow based upon an amount of thermal energy delivered to the eye over a predetermined period of time.

2. The phacoemulsification system of claim 1, wherein the matrix comprises combinations of phaco power levels, duty cycles, and fluid flow conditions that will not generate sufficient heat to create damage to eye tissue within the eye.

3. The phacoemulsification system of claim 1, further comprising a flow sensor for determining a cumulative amount of fluid removed from the eye over a predetermined amount of time.

4. The phacoemulsification system of claim 1, further comprising at least one temperature sensor for determining a temperature of at least one of the system, the eye, and a fluid within the system or the eye.

5. The phacoemulsification system of claim 1, further comprising a microprocessor for determining the matrix.

6. The phacoemulsification system of claim 5, wherein the system is configured to adjust a phaco power level based upon the fluid flow conditions.

7. The phacoemulsification system of claim 5, wherein the system is configured to adjust a phaco power duty cycle based upon the fluid flow conditions.

8. The phacoemulsification system of claim 5, wherein the system is configured to adjust a phaco power level based upon irrigation fluid flow conditions.

9. A method for regulating fluid flow and energy in a control console during ocular surgery, comprising:

providing a handpiece and a control console;

providing a matrix comprising power levels, power duty cycles, and fluid flows that will not generate sufficient heat to create a bum of eye tissue; and

controlling at least one of the phaco rower or fluid flow based upon an amount of thermal energy delivered to the eye over a predetermined period of time.

10. The method of claim 9, wherein the matrix comprises combinations of the power levels and duty cycles that will not generate sufficient heat to damage eye tissue.